GIS trade ideas
GILEAD VS COVID-19NYT: FDA PERMISSION FOR GILEAD AGAINST COVID-19 IN EMERGENCIES MAY BE ANNOUNCED ALREADY TODAY
Buy now
Sell levels on the chart
Profit +250-400 %
Wish you luck !
Top 3 Stocks NOW 🚀| April 2020😊Please LIKE & FOLLOW for more VIP Hunters signals , penny stocks
Stocks : GILD NASDAQ:GILD
What’s the Strategy here :
GILD . The company has announced of their drugs and the highest spec ability and then some scandals appeared that the drugs don't treat the disease which led to the stock to fill downhill From $83 to $75 . And after that we can see some kind of Recovery when the company announced that it was misinformation and it doesn't relate to the drugs treatment .
And now they are in the process of releasing a new drug, basically we do not care if the drug will be successful or not we care about how the stock will react to the news , and we have a high chance for the stock due to the company's spikeability in the past .
How can you actually use this ?
We ONLY trade regarding the news ! Meaning that when we see the anticipatory run UP I start trading it and letting my students and followers take the advantage 👨🎓.
The Best Part
You can follow me and apply my trades for FREE !!!
QUESTIONS ?
Please comment below , what you have in mind 😊
Gild needs to clear 82-84 areaI like it holding the dash line. The more it tests and holds, the power it accumulates.
$GILD - Please read the text below"Related: Yesterday, the WHO mistakenly posted draft documents of a Chinese study that showed remdesivir failed to improve patients' conditions.
Gilead countered that the study was underpowered for efficience since it was terminated early for low enrollment."
I'm not holding the stock.
Just had the feeling to post it!
Technically the stock remain strong!
Good-luck to all.
Gilead in tested channelGILD has seen positive price action YTD; due to combatting the COVID-19 with their drug Remdesivir.
Yesterday on the news, the trial on humans which was set in China to prove the effectivity of the drug, apparently "failed". However... The price just took us to the lower part of the channel , meaning the Risk-Reward-Ratio is at a good stance.
A close below the 50sma would change the sentiment, and remove us from the channel.
GILEAD Short Term Uptrend Trade PlanTrade Plan for Gilead Sciences.
Will look to enter at bottom of uptrend channel (75.3) , Stop Loss once uptrend broken (74).
Target Price at 86. Potential Price at 96. Personally will take profit at resistances as insurance.
Upside for Gilead:
1a) Possible treatment for Covid-19 (Remdesivir)
1b) Possible 2nd wave of virus
2) Possible FDA approval of Arthritis drug
Downside for Gilead:
1) Leaked report of Remdesivir failing in China randomized trial, which was cancelled early due to low enrollment numbers. Bears clinging on hopes that the conclusion was inaccurate due to short duration of study
$GILD Holds Bullish Posture as Key Data Looms for Top TreatmentGILD is the leader on the treatment side of the game with its remdesivir asset. The market will likely react to every new development. But the chart is very constructive at this point.
However, everything will depend on new data from trials now underway around the world.
Mainstream media has trashed Chloroquine and sold GileadThe new drug by Gilead will make certain people filthy rich
GILD just watch the boxInside the box my bias is short. Above the box my bias is long.
Targets = dotted black lines. Beware massive news risk with this name.
It can explode in the either direction on one tweet.
GILD Looking for a Long Entry After the Gap UpSUMMARY: Looking for a long entry on Gilead Sciences (GILD) after the gap up on news of a COVID treatment.
HEADLINE: Looking for a Long Entry After the Gap Up
TICKER: GILD
STRATEGY USED: Silver Scalper
Trend Confirmation = Range MA
Entry Signal = Bull/Bear Power
Exit Signal = Bull/Bear Power OR Range MA
---
DESCRIPTION:
1. With this strategy we enter long on Bull signals and exit on Bear signals when the trend is bullish.
2. The current trend on GILD is bullish according to our Alpha RMA (Green bar color).
3. We are currently looking for a Bull signal for a long entry.
4. We expect a stop and go off of S1 to get our long entry.
5. If we get the long entry at S1 we will be looking at R1 to see how the price reacts.
6. If S1 can't hold we will watching for a Bull signal in the S2 range.
---
NOTE: We conduct market analysis on a daily basis from a trend trading perspective using our own in house built tools. If you like any of the content we provide please leave a like and a follow to show your appreciation.
Gild updateIn the recent activities, every pop was sold. However, the stock has been making well "planned" higher lows. If it can close above at a local new high, you know what to do....
GileadGILD- If you didn't hear the news, yesterday Gilead labs were accredited with a drug that has been positively treating COVID19 patients. I checked the price and it is very expensive already. I had a look at the chart today and noticed that the last time this stock crossed golden (50/200 MA) on the weekly, it skyrocketed. On top of that, it held support like a champ. That moment is about to happen yet again. It is high risk due to price, you have to allocate less shares to spare your capital and an appropriate stop loss is at the weekly 200 MA. You must be ok to lose about $12 a share if the trade goes south but I see a massive opportunity in the works.
Gilead lifts the entire marketOptimism that Remdesivir is effective in the fight against Covid-19 has lifted the markets today
STAT reports that a Chicago hospital treating severe Covid-19 patients with Gilead Sciences’(GILD) antiviral medicine remdesivir is; "seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week"
FOMO ON FRIDAYDespite this being a long term investment since trials take over a year to be proven. This will make a good stock for short selling because of FOMO on fridays from new investors.
It's already all over the major media.
5 wave up? Did not expect this. Been holding Jan 80c during his roller-coaster..... Had too much fun
$GILD Gets Ready to Wag the DowGILD shares will open in the $90 area, it would appear (on Thursday evening). The hints on Remdesivir results for COVID-19 treatment suggest a significant response among severe patients.
Given that the world hangs in the balance, the stakes couldn't be higher. This stock will be the tail wagging the S&P for the next week.
